Patients who are prescribed higher daily doses of the medication buprenorphine for opioid use disorder are significantly more ...
March 22, 2026 – National Institutes of Health (NIH) released the following: ...
In a clinical trial supported by the National Institutes of Health (NIH), a research team found that administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder ...
In a clinical trial supported by the National Institutes of Health (NIH), a research team found that administering weekly injectable extended-release ...
MedPage Today on MSN
Extended-release buprenorphine viable, safe during pregnancy
Weekly injections led to higher opioid abstinence rate, with good infant outcomes ...
HealthDay on MSN
Injectable, extended-release buprenorphine feasible for opioid use disorder during pregnancy
Injectable, extended-release buprenorphine is safe and effective in pregnant women with opioid use disorder (OUD), according to a study published online March 16 in JAMA Internal Medicine. T. John ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results